Evidence map›Paper›PMID 30319612›Full record

ReviewFrontiers in immunology2018

Mapping Determinants of Cytokine Signaling via Protein Engineering.

Claire Gorby, Jonathan Martinez-Fabregas, Stephan Wilmes, Ignacio Moraga

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Claire GorbyDivision of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Jonathan Martinez-FabregasDivision of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Stephan WilmesDivision of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Ignacio MoragaDivision of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
University of Dundee · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Cytokines comprise a large family of secreted ligands that are critical for the regulation of immune homeostasis. Cytokines initiate signaling via dimerization or oligomerization of the cognate receptor subunits, triggering the activation of the Janus Kinases (JAKs)/ signal transducer and activator of transcription (STATs) pathway and the induction of specific gene expression programs and bioactivities. Deregulation of cytokines or their downstream signaling pathways are at the root of many human disorders including autoimmunity and cancer. Identifying and understanding the mechanistic principles that govern cytokine signaling will, therefore, be highly important in order to harness the therapeutic potential of cytokines. In this review, we will analyze how biophysical (ligand-receptor binding geometry and affinity) and cellular (receptor trafficking and intracellular abundance of signaling molecules) parameters shape the cytokine signalosome and cytokine functional pleiotropy; from the initial cytokine binding to its receptor to the degradation of the cytokine receptor complex in the proteasome and/or lysosome. We will also discuss how combining advanced protein engineering with detailed signaling and functional studies has opened promising avenues to tackle complex questions in the cytokine signaling field.

Indexed as

Protein EngineeringCytokinesHomeostasisHumansJanus KinasesReceptors, CytokineSignal TransductionSTAT Transcription FactorsCytokinesJanus KinasesReceptors, CytokineSTAT Transcription Factorscytokine signalingendosomal traffickingendosomes signalingJAK/STAT signaling pathwayprotein engineering

Identifiers

PMID30319612
PMCPMC6170656
OpenAlexW2894017854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.